Results for tag: "Tolcapone"

Tolcapone is a centrally acting drug used to treat Parkinson's disease. It is a catechol-O-methyltransferase (COMT) inhibitor, which works by blocking the enzyme responsible for breaking down dopamine in the brain. This helps to increase the amount of dopamine available to the brain, which can improve motor symptoms of Parkinson's disease. Tolcapone is usually used in combination with other medications, such as levodopa, to maximize its effectiveness. Tolcapone is a relatively new drug, and is not widely available. It is currently approved for use in the United States, Canada, and Europe, but is not approved in other countries. The market for Tolcapone is small, but growing, as more people are diagnosed with Parkinson's disease and become aware of the potential benefits of this drug. Some companies in the Tolcapone market include Merck, Novartis, and Teva Pharmaceuticals. Show Less Read more